A Phase 4 interventional study of Paracetamol and Ibuprofen in Low Back Pain, sponsored by Pamukkale University. Status unknown. Open to participants aged 21 Years to 80 Years. Per ClinicalTrials.gov, last updated 2016-07-19.
Sponsored by Pamukkale University · Phase 4, Interventional, and Treatment
Currently, Paracetamol and Ibuprofen are widely used by emergency physicians in Turkey for the pain treatments.
The objective of the study was to assess whether intravenous Paracetamol has superior Low Back Pain reduction will compare with Ibuprofen in emergency department (ED) adults.
Half of the participants will receive Paracetamol and the other half will receive Ibuprofen.
Paracetamol and Ibuprofen each relieve pain with different mechanisms.
Paracetamol is termed a simple analgesic and an antipyretic. Despite enduring assertions that it acts by inhibition of cyclooxygenase (COX)-mediated production of prostaglandins, unlike non-steroidal anti-inflammatory drugs (NSAIDs).
Ibuprofen is the most commonly used and most frequently prescribed NSAID. It is a non-selective inhibitor of cyclo-oxygenase-1 (COX-1) and Cyclooxygenase-2 (COX-2).4 Although its anti inflammatory properties may be weaker than those of some other NSAIDs, it has a prominent analgesic and antipyretic role.
In the investigators trial; The investigators aimed to compare intravenous Paracetamol and Ibuprofen in patient with Low Back Pain
2,875 studies on the registry are indexed under Low Back Pain; 484 are open to participants now.
This study's planned enrollment of 200 is above the median of 60 across 2,315 interventional studies indexed under Low Back Pain.
Browse Low Back Pain studies →Pamukkale University is the lead sponsor of 340 studies on the registry; 62 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
First Group: 1000 mg Paracetamol in 150 ml normal saline given as a slow intravenous infusion over 5 minutes. (100 ml of saline is removed before the addition of the 100 ml paracetamol to be the same volume)
Drug: Paracetamol
Second Group: 800 mg Ibuprofen in 150 ml normal saline given as a slow intravenous infusion over 5 minutes
Drug: Ibuprofen
1000 mg Paracetamol in 150 ml normal saline given as a slow intravenous infusion over 5 minutes.
Also known as: PERFALGAN, PARTEMOL, PAROL
800 mg Ibuprofen in 150 ml normal saline given as a slow intravenous infusion over 5 minutes
Also known as: intrafen, Caldolon
Reduction of Low Back Pain on the Visual Analog Scale
Time frame: Low Back Pain scores will be recorded at 0, 15, and 30 min on a VAS of 1 to 10
Adverse events
30th minutes after the study drug administered
Time frame: 30th minutes after the study drug administered
No study locations are listed for this record.
Plan to share: Undecided
No publications or documents are linked to this record.
This study is status unknown, as verified in Jul 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Acetaminophen · Ibuprofen